metformin	is a	drug
metformin	treats	type 2 diabetes
metformin	reduces	hepatic glucose production
metformin	improves	insulin sensitivity
metformin	causes	lactic acidosis
metformin	contraindicated in	renal failure
metformin	dosage	500‑2000 mg/day
metformin	brand	Glucophage
metformin	generic	metformin hydrochloride
metformin	side effect	gastrointestinal upset
metformin	interacts with	alcohol
metformin	increases	risk of vitamin B12 deficiency
metformin	recommended in	overweight patients
metformin	improves	lipid profile
metformin	reduces	cardiovascular events
metformin	first‑line	therapy
metformin	combined with	sulfonylureas
metformin	combined with	insulin
metformin	combined with	GLP‑1 agonists
metformin	combined with	SGLT2 inhibitors
sulfonylureas	are a	drug class
sulfonylureas	stimulate	pancreatic β‑cells
sulfonylureas	cause	hypoglycemia
sulfonylureas	contraindicated in	severe renal impairment
sulfonylureas	include	glipizide
sulfonylureas	include	glyburide
sulfonylureas	include	glimepiride
sulfonylureas	dosage	5‑20 mg/day
sulfonylureas	side effect	weight gain
sulfonylureas	interact with	CYP2C9 inhibitors
sulfonylureas	used with	metformin
sulfonylureas	used with	insulin
sulfonylureas	contraindicated in	type 1 diabetes
sulfonylureas	contraindicated in	pregnancy
sulfonylureas	brand	Diamicron
sulfonylureas	brand	Roflux
sulfonylureas	brand	Amaryl
insulin	is a	hormone
insulin	treats	type 1 diabetes
insulin	treats	type 2 diabetes
insulin	reduces	blood glucose
insulin	causes	hypoglycemia
insulin	requires	self‑monitoring
insulin	available as	rapid‑acting
insulin	available as	long‑acting
insulin	brand	Humulin
insulin	brand	Lantus
insulin	brand	Novolog
insulin	dosage	individualized
insulin	interacts with	beta‑blockers
insulin	contraindicated in	severe hypoglycemia
insulin	contraindicated in	pregnancy
GLP‑1 agonists	are a	drug class
GLP‑1 agonists	stimulate	insulin secretion
GLP‑1 agonists	suppress	glucagon release
GLP‑1 agonists	cause	nausea
GLP‑1 agonists	cause	weight loss
GLP‑1 agonists	contraindicated in	pancreatitis
GLP‑1 agonists	include	exenatide
GLP‑1 agonists	include	liraglutide
GLP‑1 agonists	include	dulaglutide
GLP‑1 agonists	dosage	0.6‑1.8 mg/week
GLP‑1 agonists	brand	Byetta
GLP‑1 agonists	brand	Victoza
GLP‑1 agonists	brand	Trulicity
SGLT2 inhibitors	are a	drug class
SGLT2 inhibitors	inhibit	renal glucose reabsorption
SGLT2 inhibitors	cause	glucosuria
SGLT2 inhibitors	cause	genital infections
SGLT2 inhibitors	cause	ketoacidosis
SGLT2 inhibitors	contraindicated in	severe renal impairment
SGLT2 inhibitors	include	canagliflozin
SGLT2 inhibitors	include	dapagliflozin
SGLT2 inhibitors	include	empagliflozin
SGLT2 inhibitors	dosage	10‑25 mg/day
SGLT2 inhibitors	brand	Invokana
SGLT2 inhibitors	brand	Jardiance
SGLT2 inhibitors	brand	Farxiga
DPP‑4 inhibitors	are a	drug class
DPP‑4 inhibitors	inhibit	DPP‑4 enzyme
DPP‑4 inhibitors	increase	GLP‑1 levels
DPP‑4 inhibitors	cause	mild hypoglycemia
DPP‑4 inhibitors	contraindicated in	severe renal impairment
DPP‑4 inhibitors	include	sitagliptin
DPP‑4 inhibitors	include	saxagliptin
DPP‑4 inhibitors	include	linagliptin
DPP‑4 inhibitors	dosage	100‑200 mg/day
DPP‑4 inhibitors	brand	Januvia
DPP‑4 inhibitors	brand	Onglyza
DPP‑4 inhibitors	brand	Glyxambi
alpha‑glucosidase inhibitors	are a	drug class
alpha‑glucosidase inhibitors	delay	carbohydrate absorption
alpha‑glucosidase inhibitors	cause	flatulence
alpha‑glucosidase inhibitors	contraindicated in	severe hepatic disease
alpha‑glucosidase inhibitors	include	acarbose
alpha‑glucosidase inhibitors	include	miglitol
alpha‑glucosidase inhibitors	dosage	25‑100 mg/day
alpha‑glucosidase inhibitors	brand	Precose
alpha‑glucosidase inhibitors	brand	Glucopone
alpha‑glucosidase inhibitors	brand	Glyset
